The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

ARIAD Pharmaceuticals

  • ARIA
  • NASDAQ
  • Consumer Products
  • Latest 5.80
  • Currency US$
  • Change 0.36
  • Percent Change 6.618 %
  • Volume 8,127,571
  • Mon Oct 20, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
  • Open 5.45
  • Previous Close 5.44
  • High 5.86
  • Low 5.44
  • Bidx6 5.77
  • Askx12 5.80
  • 52-week High01/24 9.83
  • 52-week Low10/31 2.15
  • Beta 1.383
  • Market Cap 1,080.66M
  • EPS -1.33
  • P/E
  • Forward P/E
  • PEG
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $50,870,000
  • Earnings $-259,310,000
  • Return on Equity n/a

Cash Flow

  • Cash Flow --
  • Cash $182,970,000
  • Current Ratio 2.96

12 months ended Mar 31, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $345,650,000
  • Liabilities $200,460,000
  • Liabilities-to-Equity Ratio 1.38

Price Ratios

  • Price to Sales 21.24
  • Price to Book 7.45
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Aug 6 $-0.27 Nov 5 $-0.30
Surprises Aug 6 11.11% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Oct 20, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Ariad Pharmaceuticals is engaged in the discovery and development of novel pharmaceuticals based on intracellular signaling technology. The Company has established highly integrated capabilities in functional genomics, molecular cell biology, structure based drug design, combinatorial chemistry and pharmacology. The company is developing small-molecule drugs that block signal transduction pathways in cells responsible for osteoporosis, and immune and inflammatory diseases.

Related Securities
Symbol Type Latest % Chg

Officers

  • Harvey J. Berger, M.D. Chairman of the Board of Direc
  • Edward M. Fitzgerald Executive Vice President; Chie
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

26 LANDSDOWNE ST
CAMBRIDGE, MA
02139

Phone: (617)-494-0400
Fax: (617)-4948144

kendra.adams@ariad.com
www.ariad.com

Ideas & Discussion

Live Discussion of ARIA on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.